SBIR-STTR Award

Development of Caco-2 Cells Expressing Cytochromes P450
Award last edited on: 6/1/09

Sponsored Program
SBIR
Awarding Agency
NIH : NIGMS
Total Award Amount
$581,345
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Charles L Crespi

Company Information

Gentest Corporation

6 Henshaw Street
Woburn, MA 01801
   (781) 935-5115
   N/A
   www.gentest.com
Location: Single
Congr. District: 05
County: Middlesex

Phase I

Contract Number: 1R43GM052270-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1995
Phase I Amount
$100,000
We will evaluate the feasibility of expressing human cytochrome P450 (CYP) cDNAs in Caco-2 human intestinal epithelial cells, a model system for the study of drug/xenobiotic uptake and transport. Expression studies will be conducted using CYP2A6 as a convenient and appropriate model enzyme and then extended to CYP3A4, the major cytochrome P450 in human intestinal epithelium. The suitability of transfected cells for studies of xenobiotic transport will also be evaluated. The overall goal is to develop Caco-2 cell derivatives which express the human cytochrome P4SOs found in the intestine in vivo in order to establish a better in vitro model system for drug transport / metabolism and for detecting the potential therapeutically relevant drug-drug or drug-nutrient interactions.National Institute of General Medical Sciences (NIGMS)

Phase II

Contract Number: 2R44GM052270-02A1
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
1997
(last award dollars: 1998)
Phase II Amount
$481,345

We propose to evaluate the feasibility of expressing human cytochrome P450 (CYP) cDNAs in Caco-2 human intestinal epithelial cells, a model system for the study of drug/xenobiotic uptake and transport. Expression studies will be conducted using CYP2A6 as a convenient and appropriate model enzyme and then extended to CYP3A4, the major cytochrome P450 in human intestinal epithelium. The suitability of transfected cells for studies of xenobiotic transport will also be evaluated. The overall goal is to develop Caco-2 cell derivatives which express the human cytochrome P450s found in the intestine in vivo in order to establish a better in vitro model system for drug transport / metabolism and for detecting the potential therapeutically relevant drug-drug or drug-nutrient interactions.Proposed commercial application:An improved in vitro model system to study drug metabolism and uptake. A useful system to help choose which drug candidates should be developed.Thesaurus termsThere are no thesaurus terms on file for this project.National Institute of General Medical Sciences (NIGMS)